SOUTH SAN FRANCISCO, Calif., Dec. 21 /PRNewswire-FirstCall/ -- Genentech, Inc. will announce its 2005 4th quarter and year-end earnings on Tuesday, January 10, 2006, after the markets close.
The announcement will be followed by a live webcast at 2:15 p.m. Pacific Time of a discussion by Genentech management of earnings and other business results. The webcast can be accessed on Genentech’s web site at http://www.gene.com and will be archived and available for replay until 5:00 p.m. Pacific Time on January 24, 2006.
A telephonic audio replay of the webcast will be available beginning at 5:15 p.m. Pacific Time on January 10, 2006 through 5:15 p.m. Pacific Time on January 17, 2006. Access numbers for this replay are: 1-800-642-1687 (U.S./Canada) and 1-706-645-9291 (international); Conference ID number is 3689902.
About Genentech
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from, or are based on, Genentech science. Genentech manufactures and commercializes multiple biotechnology products directly in the United States, and receives royalties or other income from companies that are licensed to market its products outside of the United States. The company has headquarters in South San Francisco, Calif., and is traded on the New York Stock Exchange under the symbol DNA. For additional information about the company, please visit http://www.gene.com .
Media Contact: Debra Charlesworth 650-225-2742 Caroline Pecquet 650-467-7078 Investor Contact: Diane Schrick 650-225-1599
Genentech, Inc.
CONTACT: media, Debra Charlesworth, +1-650-225-2742, or Caroline Pecquet,+1-650-467-7078, or investors, Diane Schrick, +1-650-225-1599, all ofGenentech
Web site: http://www.gene.com/
